2011
DOI: 10.1161/hypertensionaha.111.174367
|View full text |Cite
|
Sign up to set email alerts
|

Treatment Intensification in a Hypertension Telemanagement Trial

Abstract: Abstract-Clinical inertia represents a barrier to hypertension management. As part of a hypertension telemanagement trial designed to overcome clinical inertia, we evaluated study physician reactions to elevated home blood pressures. We studied 296 patients from the Hypertension Intervention Nurse Telemedicine Study who received telemonitoring and study physician medication management. When a patient's 2-week mean home blood pressure was elevated, an "intervention alert" prompted study physicians to consider t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
32
1
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(35 citation statements)
references
References 29 publications
1
32
1
1
Order By: Relevance
“…As described in the methods section, the behavioral intervention, which was combined with medication management in the combined arm, covered many of the psychosocial and disease-perception issues that may impact blood pressure control. Further, it has been previously reported, using HINTS data, that patient race was not associated with study physicians' deciding to intensify medication regimens, 15 indicating that results in this paper were not the result of differing medication treatment decisions. The combination of the medication management and addressing psychosocial factors related to hypertension may have impacted different issues among African American and white patients.…”
Section: Discussionmentioning
confidence: 44%
See 1 more Smart Citation
“…As described in the methods section, the behavioral intervention, which was combined with medication management in the combined arm, covered many of the psychosocial and disease-perception issues that may impact blood pressure control. Further, it has been previously reported, using HINTS data, that patient race was not associated with study physicians' deciding to intensify medication regimens, 15 indicating that results in this paper were not the result of differing medication treatment decisions. The combination of the medication management and addressing psychosocial factors related to hypertension may have impacted different issues among African American and white patients.…”
Section: Discussionmentioning
confidence: 44%
“…14 The study physician reviewed the patient's BP, medication, and adherence (based on patient report and prescription refill data) with the nurse and decided whether to change hypertension medication. 15 The nurse communicated recommended changes to the patient, while the study physician electronically prescribed the medication and generated a note in the patient's medical record that was co-signed by the patient's primary care provider. The nurse called the patient 3 weeks after the medication change to obtain reports of adverse effects and address patient questions.…”
mentioning
confidence: 99%
“…conclude their work on hypertension telemanagement with: “ However, when physicians did not intensify treatment, it was because blood pressure was closer to an acceptable threshold, and repeat blood pressure elevations occurred less frequently. Failure to intensify treatment when home blood pressure is elevated may, at times, represent good clinical judgment, not clinical inertia ” [41], and Kennedy and Mac Lean stated: “ It is important to distinguish clinical inertia from modified therapeutic goals ” [45]. …”
Section: Resultsmentioning
confidence: 99%
“…Moreover, gender disparities are reported by some, with women more likely to suffer than men as a result of clinical inertia with regard to the prevention of cardiovascular disease 27,28. However, other studies report no evidence of gender issues in relation to clinical inertia,29 so the evidence is inconsistent. Last but not least, limited reimbursement, socioeconomic and cultural disparity in terms of affordability or acceptability of a prescribed treatment, or lack of health care availability for underserved populations are all significant barriers to treatment modification according to guidelines 6,17,18…”
Section: Resultsmentioning
confidence: 99%